​
​

Arcturus Therapeutics Ownership | Who Owns Arcturus Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Arcturus Therapeutics Ownership Summary

Arcturus Therapeutics is owned by 97.43% institutional investors, 8.46% insiders. Federated hermes is the largest institutional shareholder, holding 17.41% of ARCT shares. Federated Hermes Kaufmann R is the top mutual fund, with 9.01% of its assets in Arcturus Therapeutics shares.

ARCT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArcturus Therapeutics97.43%8.46%-5.89%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Federated Hermes Kaufmann R2.44M9.01%-
Federated Hermes Kaufmann Growth2.44M9.01%-
Federated Hermes Kaufmann Small Cap Grow2.20M8.13%-
Federated Hermes Kaufmann Small Cap A2.20M8.13%-
ARK Genomic Revolution2.09M7.72%144.38K
ARK Genomic Revolution ETF2.08M7.70%10.03K
Nikko AM ARK Pstv Chg Innovt P JPY Acc2.04M7.53%-35.03K
Vanguard Total Stock Mkt Idx Inv724.72K2.68%1.08K
SPDR® S&P Biotech ETF719.28K2.66%7.95K
iShares Russell 2000 ETF593.78K2.19%-1.33K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 15, 2024Chivukula Pad Chief Scientific Officer & COOSell$249.12K
Jun 12, 2024SASSINE ANDY Chief Financial OfficerSell$1.60M
Jun 05, 2024Chivukula Pad Chief Scientific Officer & COOSell$5.13K
Jun 03, 2024Chivukula Pad Chief Scientific Officer & COOSell$1.04M
Mar 25, 2024Chivukula Pad Chief Scientific Officer & COOSell$610.57K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q2-3
2024 Q1-2
2023 Q4-2
2023 Q3-5

ARCT Ownership FAQ

Who Owns Arcturus Therapeutics?

Arcturus Therapeutics shareholders are primarily institutional investors at 97.43%, followed by 8.46% insiders and -5.89% retail investors. The average institutional ownership in Arcturus Therapeutics's industry, Biotech Stocks , is 45.35%, which Arcturus Therapeutics exceeds.

Who owns the most shares of Arcturus Therapeutics?

Arcturus Therapeutics’s largest shareholders are Federated hermes (4.69M shares, 17.41%), Blackrock (2.65M shares, 9.83%), and Ark investment management (1.96M shares, 7.29%). Together, they hold 34.52% of Arcturus Therapeutics’s total shares outstanding.

Does Blackrock own Arcturus Therapeutics?

Yes, BlackRock owns 9.83% of Arcturus Therapeutics, totaling 2.65M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 64.52M$. In the last quarter, BlackRock decreased its holdings by -93.164K shares, a -3.40% change.

Who is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested?

Portolan capital management is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.97% of its assets in 484.91K Arcturus Therapeutics shares, valued at 11.81M$.

Who is the top mutual fund holder of Arcturus Therapeutics shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Arcturus Therapeutics shares, with 9.01% of its total shares outstanding invested in 2.44M Arcturus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools